In Thailand, the market size value per capita for Penicillins and Streptomycins has shown a consistent upward trend, increasing from $0.69 in 2013 to $1.27 in 2023. Notably, growth accelerated significantly from 2015 onwards, with marked increments observed in 2016 and beyond. Year-on-year growth for 2022 and 2023 was 3.2%, and the compound annual growth rate (CAGR) over the last five years stood at approximately 2.4%.
Future trends to watch for include:
- The impact of healthcare reforms and increased investment in healthcare infrastructure in Thailand.
- Potential shifts in antibiotic usage due to evolving medical guidelines and emerging resistance issues.
- Economic factors influencing healthcare budgets and pharmaceutical pricing strategies.
| # | 31 Countries | US Dollars Per Capita | Last Year | |||
|---|---|---|---|---|---|---|
| 1 | 1 Italy | 11.76 | 2023 | View data | ||
| 2 | 2 New Zealand | 11.59 | 2023 | View data | ||
| 3 | 3 France | 11.21 | 2023 | View data | ||
| 4 | 4 Belgium | 11.17 | 2023 | View data | ||
| 5 | 5 United Kingdom | 10.77 | 2023 | View data | ||
| 27 | 27 Kyrgyzstan | 1.57 | 2023 | View data | ||
| 28 | 28 Estonia | 1.55 | 2023 | View data | ||
| 29 | 29 Thailand | 1.27 | 2023 | |||
| 30 | 30 Ghana | 0.63 | 2023 | View data | ||
| 31 | 31 Morocco | 0.54 | 2023 | View data | ||
